The Column Group
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
Investment stages
- Seed
Industries
- Media
- Entertainment
- Health Tech
- Fintech
- Mobile
- Retail Tech
About
The Column Group is a science-driven venture capital firm that invests in early-stage biotechnology companies, focusing on building drug discovery enterprises that leverage unique scientific platforms to develop breakthrough therapeutics.
The Column Group is a science-driven venture capital firm that invests in early-stage biotechnology companies, focusing on building drug discovery enterprises that leverage unique scientific platforms to develop breakthrough therapeutics.
Investment Thesis
TCG is a sciencedriven venture capital firm that invests in early stage drug discovery companies with unique scientific platforms that can deliver breakthrough therapeutics.
Manager's Experience
With extensive experience in private equity, the fund manager has successfully executed over 50 transactions across various sectors, including technology, healthcare, and consumer goods. Their strategic approach emphasizes operator-first investments, prioritizing management capabilities to drive growth. Active primarily in North America and Europe, they have achieved notable exits that underline their expertise in identifying high-potential companies at the growth stage. Their data-driven analysis informs investment decisions, allowing for a thematic focus that aligns with emerging market trends.
Team
Peter Svennilson
Jj Kang
James Evangelista
Adriana Tajonar
Timothy Kutzkey
Tim Kutzkey
Sue Murakami